METACARE CO., Ltd. (KRX:118000)
1,760.00
-40.00 (-2.22%)
May 21, 2026, 3:30 PM KST
METACARE CO. Revenue
In the year 2025, METACARE CO. had annual revenue of 32.82B KRW with 62.42% growth. METACARE CO. had revenue of 10.31B in the quarter ending December 31, 2025, with 84.33% growth.
Revenue
32.82B
Revenue Growth
+62.42%
P/S Ratio
0.94
Revenue / Employee
1.06B
Employees
n/a
Market Cap
30.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.82B | 12.61B | 62.42% |
| Dec 31, 2024 | 20.21B | 2.95B | 17.10% |
| Dec 31, 2023 | 17.26B | -1.84B | -9.64% |
| Dec 31, 2022 | 19.10B | 484.98M | 2.61% |
| Dec 31, 2021 | 18.61B | 11.99B | 181.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4.81T |
| Celltrion | 4.16T |
| Samsung Epis Holdings | 1.51T |
| ALTEOGEN | 215.86B |
| Dong Sung Bio Pharm.Co.,Ltd. | 78.44B |
| BCWORLD PHARM. | 75.80B |
| Aprogen Biologics | 73.23B |
| Tdspharm | 27.62B |